Literature DB >> 10933731

Characterization of a replication-defective human immunodeficiency virus type 1 att site mutant that is blocked after the 3' processing step of retroviral integration.

H Chen1, A Engelman.   

Abstract

Two activities of retroviral integrase, 3' processing and DNA strand transfer, are required to integrate viral cDNA into a host cell chromosome. Integrase activity has been analyzed in vitro using purified protein and recombinant DNA substrates that model the U3 and U5 ends of viral cDNA or by using viral preintegration complexes (PICs) that form during virus infection. Numerous studies have investigated changes in integrase or viral DNA for effects on both 3' processing and DNA strand transfer activities using purified protein, but similar analyses have not been carried out using PICs. Here, we analyzed PICs from human immunodeficiency virus type 1 (HIV-1) strain 604del, an integration-defective mutant lacking 26 bp of U5, and revE1, a revertant of 604del containing an additional 19-bp deletion, for levels of 3' processing activity that occurred in infected cells and for levels of in vitro DNA strand transfer activity. Whereas revE1 supported one-third to one-half of the level of wild-type DNA strand transfer activity, the level of 604del DNA strand transfer activity was undetectable. Surprisingly, integrase similarly processed the 3' ends of 604del and revE1 in vivo. We therefore conclude that 604del is blocked in its ability to replicate in cells after the 3' processing step of retroviral integration. Whereas Western blotting showed that wild-type, revE1, and 604del PICs contained similar levels of integrase protein, Mu-mediated PCR footprinting revealed only minimal protein-DNA complex formation at the ends of 604del cDNA. We propose that 604del is replication defective because proteins important for DNA strand transfer activity do not stably associate with this cDNA after in vivo 3' processing by integrase.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10933731      PMCID: PMC112354          DOI: 10.1128/jvi.74.17.8188-8193.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Two bases are deleted from the termini of HIV-1 linear DNA during integrative recombination.

Authors:  C D Pauza
Journal:  Virology       Date:  1990-12       Impact factor: 3.616

2.  Removal of 3'-OH-terminal nucleotides from blunt-ended long terminal repeat termini by the avian retrovirus integration protein.

Authors:  A C Vora; M L Fitzgerald; D P Grandgenett
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

3.  Relationship of avian retrovirus DNA synthesis to integration in vitro.

Authors:  Y M Lee; J M Coffin
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

4.  The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro.

Authors:  R A Katz; G Merkel; J Kulkosky; J Leis; A M Skalka
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

5.  Structure of the termini of DNA intermediates in the integration of retroviral DNA: dependence on IN function and terminal DNA sequence.

Authors:  M J Roth; P L Schwartzberg; S P Goff
Journal:  Cell       Date:  1989-07-14       Impact factor: 41.582

6.  Correct integration of retroviral DNA in vitro.

Authors:  P O Brown; B Bowerman; H E Varmus; J M Bishop
Journal:  Cell       Date:  1987-05-08       Impact factor: 41.582

7.  Integration of human immunodeficiency virus type 1 DNA in vitro.

Authors:  C M Farnet; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

8.  Human immunodeficiency virus integration protein expressed in Escherichia coli possesses selective DNA cleaving activity.

Authors:  P A Sherman; J A Fyfe
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

9.  The IN protein of Moloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro.

Authors:  R Craigie; T Fujiwara; F Bushman
Journal:  Cell       Date:  1990-08-24       Impact factor: 41.582

10.  Human immunodeficiency virus integration in a cell-free system.

Authors:  V Ellison; H Abrams; T Roe; J Lifson; P Brown
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

View more
  9 in total

1.  Asymmetric processing of human immunodeficiency virus type 1 cDNA in vivo: implications for functional end coupling during the chemical steps of DNA transposition.

Authors:  H Chen; A Engelman
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

2.  Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo.

Authors:  Stéphanie Philippe; Chamsy Sarkis; Martine Barkats; Hamid Mammeri; Charline Ladroue; Caroline Petit; Jacques Mallet; Che Serguera
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-09       Impact factor: 11.205

3.  A phenotypic recessive, post-entry block in rabbit cells that results in aberrant trafficking of HIV-1.

Authors:  Teresa Cutiño-Moguel; Ariberto Fassati
Journal:  Traffic       Date:  2006-08       Impact factor: 6.215

4.  Genetic analyses of DNA-binding mutants in the catalytic core domain of human immunodeficiency virus type 1 integrase.

Authors:  Richard Lu; Ana Limón; Hina Z Ghory; Alan Engelman
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

5.  Quantitative analysis of HIV-1 preintegration complexes.

Authors:  Alan Engelman; Ilker Oztop; Nick Vandegraaff; Nidhanapati K Raghavendra
Journal:  Methods       Date:  2009-02-20       Impact factor: 3.608

6.  Inhibition of human immunodeficiency virus type 1 concerted integration by strand transfer inhibitors which recognize a transient structural intermediate.

Authors:  Krishan K Pandey; Sibes Bera; Jacob Zahm; Ajaykumar Vora; Kara Stillmock; Daria Hazuda; Duane P Grandgenett
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

7.  Nuclear localization of human immunodeficiency virus type 1 preintegration complexes (PICs): V165A and R166A are pleiotropic integrase mutants primarily defective for integration, not PIC nuclear import.

Authors:  Ana Limón; Eric Devroe; Richard Lu; Hina Z Ghory; Pamela A Silver; Alan Engelman
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

8.  Design of cell-permeable stapled peptides as HIV-1 integrase inhibitors.

Authors:  Ya-Qiu Long; Shao-Xu Huang; Zahrah Zawahir; Zhong-Liang Xu; Huiyuan Li; Tino W Sanchez; Ying Zhi; Stephanie De Houwer; Frauke Christ; Zeger Debyser; Nouri Neamati
Journal:  J Med Chem       Date:  2013-06-24       Impact factor: 7.446

9.  A novel function for spumaretrovirus integrase: an early requirement for integrase-mediated cleavage of 2 LTR circles.

Authors:  Olivier Delelis; Caroline Petit; Herve Leh; Gladys Mbemba; Jean-François Mouscadet; Pierre Sonigo
Journal:  Retrovirology       Date:  2005-05-18       Impact factor: 4.602

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.